Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
Clinical trial NCT00104299 · COMPLETED
Trial details
- NCT number
- NCT00104299
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2008-12-01
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.